Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Clinical trial NCT00096044 · COMPLETED
Trial details
- NCT number
- NCT00096044
- Sponsor
- Roswell Park Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Primary completion
- 2015-06-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.